What are the risks of second medical use and dosing regimens in pharmaceutical patenting?

Pharm Pat Anal. 2014 Sep;3(5):481-4. doi: 10.4155/ppa.14.37.

Authors

Christine Kanz¹, Florian Gerhardt

Affiliation

¹ Reimann Osterrieth Köhler Haft, Steinstraße 20, 40212 Düsseldorf, Germany.

PMID: 25374316
DOI: 10.4155/ppa.14.37

No abstract available

Keywords: advertising material; customized formulation; dosing regimen; scope of protection; second medical use; specific purpose.

MeSH terms

Dose-Response Relationship, Drug
Drug Industry / legislation & jurisprudence*
Drug Repositioning*
Off-Label Use / legislation & jurisprudence*
Patents as Topic / legislation & jurisprudence*
Pharmaceutical Preparations / administration & dosage*

Substances

Pharmaceutical Preparations